MARSEL KOGAN: Open Payments
NPI 1487276853 · MERRITT ISLAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,711 in 52 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,711
Food & beverage: $1,711
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $372 |
| ABBVIE INC. | 15 | $339 |
| Alkermes, Inc. | 6 | $253 |
| Vanda Pharmaceuticals Inc. | 8 | $237 |
| Axsome Therapeutics, Inc. | 2 | $128 |
| Neurocrine BioSciences, Inc. | 4 | $109 |
| Teva Pharmaceuticals USA, Inc. | 3 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $59 |
| LivaNova USA, Inc. | 1 | $32 |
Products named: CAPLYTA, VRAYLAR, ARISTADA, FANAPT, Auvelity, INGREZZA, AUSTEDO XR, TRINTELLIX.
Industry payments across FL — which companies pay providers there.
